Nilotinib cause moyamoya disease in the treatment of chronic myelogenous leukemia during chronic phase: A case report
Jin-ping Liang,
Rui-hua Mi,
Lin Chen,
Xu-dong Wei
Affiliations
Jin-ping Liang
Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China
Rui-hua Mi
Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China
Lin Chen
Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China
Xu-dong Wei
Corresponding author. Department of Hematology, the Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, No. 127 Dongming Rd, Zhengzhou, 450008, Henan, China.; Department of Hematology, The Affiliated Tumor Hospital of Zhengzhou University, Henan Provincial Cancer Hospital, Zhengzhou, China